Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew D Dick

Showing results (171-180 of 245) with videos related to

Pageof 25
Sort By:
Molecular Vision|February 5, 2013
Tumor necrosis factor polymorphisms associated with tumor necrosis factor production influence the risk of idiopathic intermediate uveitisDenize Atan, Jarka Heissigerova, Lucia Kuffová, et al.
The Journal of Rheumatology|October 3, 2013
The safety and efficacy of noncorticosteroid triple immunosuppressive therapy in the treatment of refractory chronic noninfectious uveitis in childhoodJessica A Little, Ethan S Sen, Helen Strike, et al.
Experimental Eye Research|March 19, 2025
Breaking Bruch's: How changes in Bruch's membrane influence retinal homeostasisSimon J Clark, Christine Curcio, Andrew D Dick, et al.
The British Journal of Ophthalmology|December 3, 2020
Corneal Transplant Follow-up Study II: a randomised trial to determine whether HLA class II matching reduces the risk of allograft rejection in penetrating keratoplastyW John Armitage, Helen L Winton, Mark N A Jones, et al.
Ocular Immunology and Inflammation|November 8, 2022
Infectious Uveitis: Conversations with the ExpertsRupesh Agrawal, Zheng Xian Thng, Amod Gupta, et al.
Discovery Immunology|May 29, 2026
A pathogenic CD4 T cell phenotype in experimental uveitis shares common features with other immune mediated inflammatory diseasesAmy Ward, Oliver H Bell, Luis Martinez-Robles, et al.
Progress in Retinal and Eye Research|March 14, 2018
Re-programming immunosurveillance in persistent non-infectious ocular inflammationSimon J Epps, Joanne Boldison, Madeleine L Stimpson, et al.
Nature Communications|July 28, 2019
A systems biology approach towards understanding and treating non-neovascular age-related macular degenerationJames T Handa, Cathy Bowes Rickman, Andrew D Dick, et al.
The American Journal of Pathology|June 30, 2007
Monoclonal antibody-mediated CD200 receptor signaling suppresses macrophage activation and tissue damage in experimental autoimmune uveoretinitisDavid A Copland, Claudia J Calder, Ben J E Raveney, et al.
JCI Insight|April 22, 2021
Interleukin-33 regulates metabolic reprogramming of the retinal pigment epithelium in response to immune stressorsLouis M Scott, Emma E Vincent, Natalie Hudson, et al.
Pageof 25

Showing results (171-180 of 245) with videos related to

Sort By:
Pageof 25
Molecular Vision|February 5, 2013
Tumor necrosis factor polymorphisms associated with tumor necrosis factor production influence the risk of idiopathic intermediate uveitisDenize Atan, Jarka Heissigerova, Lucia Kuffová, et al.
The Journal of Rheumatology|October 3, 2013
The safety and efficacy of noncorticosteroid triple immunosuppressive therapy in the treatment of refractory chronic noninfectious uveitis in childhoodJessica A Little, Ethan S Sen, Helen Strike, et al.
Experimental Eye Research|March 19, 2025
Breaking Bruch's: How changes in Bruch's membrane influence retinal homeostasisSimon J Clark, Christine Curcio, Andrew D Dick, et al.
The British Journal of Ophthalmology|December 3, 2020
Corneal Transplant Follow-up Study II: a randomised trial to determine whether HLA class II matching reduces the risk of allograft rejection in penetrating keratoplastyW John Armitage, Helen L Winton, Mark N A Jones, et al.
Ocular Immunology and Inflammation|November 8, 2022
Infectious Uveitis: Conversations with the ExpertsRupesh Agrawal, Zheng Xian Thng, Amod Gupta, et al.
Discovery Immunology|May 29, 2026
A pathogenic CD4 T cell phenotype in experimental uveitis shares common features with other immune mediated inflammatory diseasesAmy Ward, Oliver H Bell, Luis Martinez-Robles, et al.
Progress in Retinal and Eye Research|March 14, 2018
Re-programming immunosurveillance in persistent non-infectious ocular inflammationSimon J Epps, Joanne Boldison, Madeleine L Stimpson, et al.
Nature Communications|July 28, 2019
A systems biology approach towards understanding and treating non-neovascular age-related macular degenerationJames T Handa, Cathy Bowes Rickman, Andrew D Dick, et al.
The American Journal of Pathology|June 30, 2007
Monoclonal antibody-mediated CD200 receptor signaling suppresses macrophage activation and tissue damage in experimental autoimmune uveoretinitisDavid A Copland, Claudia J Calder, Ben J E Raveney, et al.
JCI Insight|April 22, 2021
Interleukin-33 regulates metabolic reprogramming of the retinal pigment epithelium in response to immune stressorsLouis M Scott, Emma E Vincent, Natalie Hudson, et al.
Pageof 25